Cutler Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-109,700
| Closed | -$16K | – | 2839 |
|
|
2023
Q4 | $16K | Buy |
109,700
+102,800
| +1,490% | +$12.5M | ﹤0.01% | 2093 |
|
|
2023
Q3 | $5K | Sell |
6,900
-2,900
| -30% | -$369K | ﹤0.01% | 2844 |
|
|
2023
Q2 | $32K | Buy |
9,800
+4,200
| +75% | +$546K | ﹤0.01% | 1562 |
|
|
2023
Q1 | $19K | Sell |
5,600
-12,600
| -69% | -$1.65M | ﹤0.01% | 1952 |
|
|
2022
Q4 | $11K | Sell |
18,200
-57,200
| -76% | -$7.39M | ﹤0.01% | 2631 |
|
|
2022
Q3 | $467K | Buy |
75,400
+55,800
| +285% | +$6.93M | 0.03% | 553 |
|
|
2022
Q2 | $202K | Sell |
19,600
-8,200
| -29% | -$973K | 0.01% | 1001 |
|
|
2022
Q1 | $358K | Sell |
27,800
-71,700
| -72% | -$9.34M | 0.02% | 827 |
|
|
2021
Q4 | $287K | Buy |
99,500
+69,200
| +228% | +$10.7M | 0.01% | 1069 |
|
|
2021
Q3 | $97K | Sell |
30,300
-59,200
| -66% | -$9.96M | ﹤0.01% | 1944 |
|
|
2021
Q2 | $116K | Sell |
89,500
-142,200
| -61% | -$21.9M | 0.01% | 1747 |
|
|
2021
Q1 | $719K | Buy |
231,700
+60,700
| +35% | +$9.64M | 0.04% | 568 |
|
|
2020
Q4 | $218K | Buy |
171,000
+121,800
| +248% | +$17.4M | 0.01% | 1038 |
|
|
2020
Q3 | $105K | Sell |
49,200
-153,500
| -76% | -$20.8M | 0.01% | 1289 |
|
|
2020
Q2 | $383K | Buy |
202,700
+189,500
| +1,436% | +$24.2M | 0.03% | 580 |
|
|
2020
Q1 | $73K | Sell |
13,200
-165,300
| -93% | -$19M | ﹤0.01% | 1523 |
|
|
2019
Q4 | $192K | Buy |
178,500
+128,500
| +257% | +$14.3M | 0.01% | 841 |
|
|
2019
Q3 | $256K | Sell |
50,000
-136,000
| -73% | -$14.2M | 0.02% | 591 |
|
|
2019
Q2 | $154K | Buy |
186,000
+152,500
| +455% | +$16.2M | 0.01% | 864 |
|
|
2019
Q1 | $116K | Sell |
33,500
-37,400
| -53% | -$4.1M | 0.01% | 932 |
|
|
2018
Q4 | $304K | Sell |
70,900
-17,600
| -20% | -$1.87M | 0.03% | 476 |
|
|
2018
Q3 | $104K | Buy |
88,500
+9,700
| +12% | +$1.14M | 0.01% | 1173 |
|
|
2018
Q2 | $178K | Sell |
78,800
-68,400
| -46% | -$7.32M | 0.01% | 832 |
|
|
2018
Q1 | $657K | Sell |
147,200
-735,300
| -83% | -$81.5M | 0.06% | 327 |
|
|
2017
Q4 | $704K | Sell |
882,500
-369,700
| -30% | -$39.5M | 0.03% | 419 |
|
|
2017
Q3 | $1.28M | Sell |
1,252,200
-666,600
| -35% | -$71.2M | 0.05% | 286 |
|
|
2017
Q2 | $4.51M | Buy |
1,918,800
+718,800
| +60% | +$70.8M | 0.17% | 103 |
|
|
2017
Q1 | $2.82M | Buy |
1,200,000
+39,600
| +3% | +$3.79M | 0.12% | 154 |
|
|
2016
Q4 | $4.96M | Sell |
1,160,400
-1,203,300
| -51% | -$110M | 0.18% | 91 |
|
|
2016
Q3 | $4.71M | Buy |
2,363,700
+927,000
| +65% | +$88.2M | 0.21% | 75 |
|
|
2016
Q2 | $5.17M | Buy |
1,436,700
+551,400
| +62% | +$49.5M | 0.26% | 50 |
|
|
2016
Q1 | $4.04M | Sell |
885,300
-205,800
| -19% | -$18.4M | 0.27% | 47 |
|
|
2015
Q4 | $2.53M | Buy |
+1,091,100
| New | +$118M | 0.14% | 123 |
|
Other funds holding IBB
CB
Cutler Group's IBB Position: Q1 2024 in Review
Cutler Group sold out of iShares Biotechnology ETF (IBB) in Q1 2024, closing a stake of 200 shares — an estimated $27.3K sold.
Cutler Group first reported a position in IBB in Q4 2015 and held it in 28 quarters. The position peaked at $17.2M in Q3 2016. 899 funds tracked by Wall St. Rank hold IBB as of Q1 2024.
- Cutler Group reported no remaining iShares Biotechnology ETF position as of Q1 2024 after selling out during the quarter.
- Cutler Group sold 200 iShares Biotechnology ETF shares in Q1 2024, an estimated $27.3K.
- Cutler Group first reported a position in iShares Biotechnology ETF in Q4 2015 and held it in 28 quarters.
- Cutler Group's iShares Biotechnology ETF position peaked at $17.2M in Q3 2016.
- 899 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2024.
Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.